Hostname: page-component-7c8c6479df-94d59 Total loading time: 0 Render date: 2024-03-27T08:45:59.767Z Has data issue: false hasContentIssue false

Deletion of 22q11 chromosome is associated with postoperative morbidity after unifocalisation surgery – CORRIGENDUM

Published online by Cambridge University Press:  29 October 2018

Rights & Permissions [Opens in a new window]

Abstract

Type
Corrigendum
Copyright
© Cambridge University Press 2018 

The authors apologize for an error in the above stated paper. In the body of the paper, it is stated that “ECMO was used 44 times (20 (27%) in those with 22q11 deletion, 24 (22%) in those without) (p=0.45)”. This is also indicated in Table 2. This data is incorrect and was due to a database error. After extensive chart review, there were only 12 instances of ECMO use identified over the eight-year time period of the study. Seven (6.5%) of these occurred in patients with normal genotype and five (6.8%) in patients with 22q11 deletion. There was no significant difference between the two groups. The use of postoperative ECMO was much lower than reported in the manuscript.

Footnotes

Cite this article: Koth A, Sidell D, Bauser-Heaton H, Wise-Faberowski L, Hanley FL, McElhinney DB, Asija R. (2018) Deletion of 22q11 chromosome is associated with postoperative morbidity after unifocalisation surgery – CORRIGENDUM. Cardiology in the Young29: 23. doi: 10.1017/S1047951118001804

References

Koth, A, Sidell, D, Bauser-Heaton, H, Wise-Faberowski, L, Hanley, FL, McElhinney, DB, Asija, R. Deletion of 22q11 chromosome is associated with postoperative morbidity after unifocalisation surgery. Cardiol Young. Published by Cambridge University Press, 30 August 2018. doi: 10.1017/S1047951118001427 Google Scholar